miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5

Authors:

Abstract
Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 and KLF5’s downstream target gene FGF-BP and Cyclin D1 in TNBC cell lines HCC1806 and HCC1937. Consequently, miR-217 suppresses TNBC cell growth, migration, and invasion. MiR-217 suppresses TNBC, at least partially, through down-regulating the KLF5 expression. These results suggest that the miR-217-KLF5 axis might serve as a potential target for treatment of TNBC.
Funding Information
  • Yunnan Applied Basic Research Key Projects (2015FA027)
  • Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010303)
  • National Key Basic Research Program of China (2013CB910900)
  • National Nature Science Foundation of China (81325016 and U1602221)
  • National Nature Science Foundation of China (81672624)
  • Shanghai health system outstanding academic leader training program (XBR2013114)
  • Shanghai Municipal Commission of Health and Family Planning (20164Y0274)
  • Shanghai Fengxian District Health and Family Planning Commission Project (20131414)

This publication has 44 references indexed in Scilit: